Matrix metalloproteinases and TIMPs: properties and implications for the treatment of chronic obstructive pulmonary

T Cawston1, S Carrere, J Catterall

  • 1Department of Rheumatology, Department of Medicine, University of Newcastle, Framlington Place, Newcastle upon Tyne NE2 4HH, UK.

Novartis Foundation Symposium
|February 24, 2001
PubMed

Insights

Matrix metalloproteinases (MMPs) degrade connective tissue. Inhibiting MMPs shows promise in preventing tissue breakdown, with new drugs being tested in clinical trials for diseases like COPD.

Area of Science:

  • Biochemistry
  • Pathology
  • Pharmacology

Background:

  • Matrix metalloproteinases (MMPs) are enzymes capable of degrading connective tissue.
  • Tissue inhibitors of metalloproteinases (TIMPs) regulate MMP activity.
  • Imbalances between MMPs and TIMPs contribute to tissue breakdown in various diseases.

Purpose of the Study:

  • To investigate the role of MMPs in connective tissue degradation.
  • To evaluate the therapeutic potential of MMP inhibitors.

Main Methods:

  • Utilized transgenic mouse models to study MMP function in vivo.
  • Assessed the efficacy of novel MMP inhibitors in vitro and in animal models.

Main Results:

  • MMP1 overexpression led to pulmonary emphysema in mice.
  • MMP12 knockout mice were protected from cigarette smoke-induced emphysema.
  • Developed MMP inhibitors demonstrated effectiveness in preventing tissue destruction in preclinical studies.

Conclusions:

  • MMPs play a significant role in the pathogenesis of diseases involving connective tissue destruction.
  • Specific MMP inhibitors are a promising therapeutic strategy for preventing tissue breakdown.
  • Further clinical trials are warranted to evaluate the efficacy of these inhibitors in patients.

Related Concept Videos

Role of Matrix Metalloproteases in Degradation of ECM01:23

Role of Matrix Metalloproteases in Degradation of ECM

Matrix metalloproteases (MMPs) are enzymes involved in the hydrolysis of proteins and glycoproteins of the extracellular matrix. MMPs are essential for the migration and proliferation of cells through the dense matrix network, throughout embryonic development, and throughout morphogenesis. The first MMP activity discovered was a collagenase in a tadpole's tail undergoing metamorphosis. The active collagen deposition and modifications lead to the morphogenesis of tadpoles into the adult body.
A...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation